Terms: = Thyroid cancer AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492
13 results:
1. Construction and validation of nomograms to reduce completion thyroidectomy by predicting lymph node metastasis in low-risk papillary thyroid carcinoma.
Wang R; Tang Z; Wu Z; Xiao Y; Li J; Zhu J; Zhang X; Ming J
Eur J Surg Oncol; 2023 Aug; 49(8):1395-1404. PubMed ID: 37061404
[TBL] [Abstract] [Full Text] [Related]
2. Sleep quality, stress and thyroid cancer: a case-control study.
Afrashteh S; Fararouei M; Parad MT; Mirahmadizadeh A
J Endocrinol Invest; 2022 Jun; 45(6):1219-1226. PubMed ID: 35112324
[TBL] [Abstract] [Full Text] [Related]
3. Impact of a gene expression classifier on the long-term management of patients with cytologically indeterminate thyroid nodules.
Singer J; Hanna JW; Visaria J; Gu T; McCoy M; Kloos RT
Curr Med Res Opin; 2016 Jul; 32(7):1225-32. PubMed ID: 26973059
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant somatic hypermutations in thyroid lymphomas.
Takakuwa T; Miyauchi A; Aozasa K
Leuk Res; 2009 May; 33(5):649-54. PubMed ID: 19019431
[TBL] [Abstract] [Full Text] [Related]
5. Polymerase chain reaction-based clonality analysis in thyroid lymphoma.
Yamauchi A; Tomita Y; Takakuwa T; Hoshida Y; Nakatsuka S; Sakamoto H; Aozasa K
Int J Mol Med; 2002 Jul; 10(1):113-7. PubMed ID: 12060861
[TBL] [Abstract] [Full Text] [Related]
6. DNA sequence of immunoglobulin heavy chain variable region gene in thyroid lymphoma.
Miwa H; Takakuwa T; Nakatsuka S; Tomita Y; Matsuzuka F; Aozasa K
Jpn J Cancer Res; 2001 Oct; 92(10):1041-7. PubMed ID: 11676854
[TBL] [Abstract] [Full Text] [Related]
7. Frequent mutations of Fas gene in thyroid lymphoma.
Takakuwa T; Dong Z; Takayama H; Matsuzuka F; Nagata S; Aozasa K
Cancer Res; 2001 Feb; 61(4):1382-5. PubMed ID: 11245438
[TBL] [Abstract] [Full Text] [Related]
8. Role of hypermethylation of DAP-kinase CpG island in the development of thyroid lymphoma.
Nakatsuka S; Takakuwa T; Tomita Y; Miwa H; Matsuzuka F; Aozasa K
Lab Invest; 2000 Nov; 80(11):1651-5. PubMed ID: 11092525
[TBL] [Abstract] [Full Text] [Related]
9. Expression of interleukin-7 and its receptor in thyroid lymphoma.
Takakuwa T; Nomura S; Matsuzuka F; Inoue H; Aozasa K
Lab Invest; 2000 Oct; 80(10):1483-90. PubMed ID: 11045564
[TBL] [Abstract] [Full Text] [Related]
10. Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma.
Takakuwa T; Hongyo T; Syaifudin M; Kanno H; Matsuzuka F; Narabayashi I; Nomura T; Aozasa K
Jpn J Cancer Res; 2000 Mar; 91(3):280-6. PubMed ID: 10760686
[TBL] [Abstract] [Full Text] [Related]
11. Sporadic activation of Epstein-Barr virus in thyroid lymphoma.
Tomita Y; Ohsawa M; Kanno H; Matsuzuka F; Kuma K; Aozasa K
Leuk Lymphoma; 1995 Sep; 19(1-2):129-34. PubMed ID: 8574157
[TBL] [Abstract] [Full Text] [Related]
12. Monocytoid B-cell lymphoma arising in extranodal organs.
Aozasa K; Matsumoto M; Katagiri S; Yonezawa T; Soma T; Sugiyama H; Matsuzuka F; Kuma K
Cancer; 1991 May; 67(9):2305-10. PubMed ID: 2013038
[TBL] [Abstract] [Full Text] [Related]
13. Immunologic and immunohistochemical studies on chronic lymphocytic thyroiditis with or without thyroid lymphoma.
Aozasa K; Tajima K; Tominaga N; Katagiri S; Yonezawa T; Matsuzuka F; Kuma K; Sawada M
Oncology; 1991; 48(1):65-71. PubMed ID: 1987500
[TBL] [Abstract] [Full Text] [Related]
